| 000 | 01849 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515201406.0 | ||
| 264 | 0 | _c20100604 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1477-030X | ||
| 024 | 7 |
_a10.1177/0269216309356138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLennernäs, Bo | |
| 245 | 0 | 0 |
_aSublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study. _h[electronic resource] |
| 260 |
_bPalliative medicine _cApr 2010 |
||
| 300 |
_a286-93 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Sublingual |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDizziness _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPain Measurement _xmethods |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aFrank-Lissbrant, Ingela | |
| 700 | 1 | _aLennernäs, Hans | |
| 700 | 1 | _aKälkner, Karl Mikael | |
| 700 | 1 | _aDerrick, Rob | |
| 700 | 1 | _aHowell, Julian | |
| 773 | 0 |
_tPalliative medicine _gvol. 24 _gno. 3 _gp. 286-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269216309356138 _zAvailable from publisher's website |
| 999 |
_c19397228 _d19397228 |
||